Orbicular Pharmaceutical is a specialty pharmaceutical company that develops complex generics and drug-device combination products. Its product capabilities include injectable formulations; injector device-based peptides; drug-device combination products; ophthalmic suspensions; nasal and inhalation delivery systems; and complex iron colloidal systems. Founded in 2010 and based in Hyderabad, the company targets regulated markets under the leadership of Dr. M.S. Mohan. Orbicular plans to use the recent capital infusion to expedite development of its product pipeline and accelerate R&D efforts. The company also aims to expand its portfolio and strengthen global partnerships, according to CEO Dr. Hiren Patel. Financially, Tata Capital Healthcare Fund has invested approximately $20 million for an undisclosed equity stake to support those initiatives.

Total raised

$20M

Funding rounds

1

Latest round

Equity

Latest activity

May 2024